Hepion Total Assets from 2010 to 2024

HEPA Stock  USD 1.41  0.60  29.85%   
Hepion Pharmaceuticals' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 27.5 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2013-09-30
Previous Quarter
18.1 M
Current Value
18.1 M
Quarterly Volatility
35.6 M
 
Yuan Drop
 
Covid
Check Hepion Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hepion main balance sheet or income statement drivers, such as Depreciation And Amortization of 81.3 K, Selling General Administrative of 6.5 M or Other Operating Expenses of 47.5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 1.0E-4 or PTB Ratio of 1.86. Hepion financial statements analysis is a perfect complement when working with Hepion Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Hepion Pharmaceuticals Technical models . Check out the analysis of Hepion Pharmaceuticals Correlation against competitors.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.

Latest Hepion Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Hepion Pharmaceuticals over the last few years. Total assets refers to the total amount of Hepion Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hepion Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Hepion Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hepion Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 18.09 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Hepion Total Assets Regression Statistics

Arithmetic Mean21,866,316
Geometric Mean5,358,810
Coefficient Of Variation132.04
Mean Deviation20,333,853
Median13,106,712
Standard Deviation28,872,376
Sample Variance833.6T
Range103.5M
R-Value0.65
Mean Square Error520T
R-Squared0.42
Significance0.01
Slope4,187,883
Total Sum of Squares11670.6T

Hepion Total Assets History

202427.5 M
202318.1 M
202260.2 M
2021103.6 M
202048.6 M
201920.6 M
20188.2 M

Other Fundumenentals of Hepion Pharmaceuticals

Hepion Pharmaceuticals Total Assets component correlations

0.98-0.99-0.580.560.611.00.70.70.450.87-0.24-0.65-0.030.940.940.03-0.03-0.32-0.03-0.030.37
0.98-0.99-0.460.470.50.980.70.590.480.79-0.13-0.570.110.980.970.00.11-0.180.110.110.36
-0.99-0.990.53-0.53-0.57-1.0-0.72-0.65-0.43-0.840.20.63-0.03-0.97-0.970.02-0.030.24-0.03-0.03-0.37
-0.58-0.460.53-0.56-0.7-0.57-0.19-0.98-0.17-0.870.840.880.68-0.34-0.38-0.060.680.730.680.68-0.35
0.560.47-0.53-0.560.810.540.470.580.180.62-0.32-0.39-0.170.40.42-0.01-0.17-0.27-0.17-0.170.23
0.610.5-0.57-0.70.810.580.550.70.120.71-0.44-0.56-0.240.40.40.24-0.24-0.3-0.24-0.240.28
1.00.98-1.0-0.570.540.580.690.70.420.87-0.26-0.68-0.040.950.96-0.02-0.04-0.31-0.04-0.040.38
0.70.7-0.72-0.190.470.550.690.280.050.42-0.05-0.320.30.660.630.210.30.090.30.30.5
0.70.59-0.65-0.980.580.70.70.280.210.94-0.8-0.92-0.650.480.53-0.01-0.65-0.74-0.65-0.650.36
0.450.48-0.43-0.170.180.120.420.050.210.360.210.030.150.450.42-0.050.15-0.110.150.15-0.12
0.870.79-0.84-0.870.620.710.870.420.940.36-0.58-0.87-0.460.720.75-0.03-0.46-0.62-0.46-0.460.27
-0.24-0.130.20.84-0.32-0.44-0.26-0.05-0.80.21-0.580.830.74-0.05-0.110.190.740.690.740.74-0.54
-0.65-0.570.630.88-0.39-0.56-0.68-0.32-0.920.03-0.870.830.62-0.51-0.570.170.620.670.620.62-0.44
-0.030.11-0.030.68-0.17-0.24-0.040.3-0.650.15-0.460.740.620.190.120.121.00.91.01.00.07
0.940.98-0.97-0.340.40.40.950.660.480.450.72-0.05-0.510.190.99-0.140.19-0.10.190.190.35
0.940.97-0.97-0.380.420.40.960.630.530.420.75-0.11-0.570.120.99-0.210.12-0.160.120.120.35
0.030.00.02-0.06-0.010.24-0.020.21-0.01-0.05-0.030.190.170.12-0.14-0.210.120.140.120.12-0.12
-0.030.11-0.030.68-0.17-0.24-0.040.3-0.650.15-0.460.740.621.00.190.120.120.91.01.00.07
-0.32-0.180.240.73-0.27-0.3-0.310.09-0.74-0.11-0.620.690.670.9-0.1-0.160.140.90.90.9-0.11
-0.030.11-0.030.68-0.17-0.24-0.040.3-0.650.15-0.460.740.621.00.190.120.121.00.91.00.07
-0.030.11-0.030.68-0.17-0.24-0.040.3-0.650.15-0.460.740.621.00.190.120.121.00.91.00.07
0.370.36-0.37-0.350.230.280.380.50.36-0.120.27-0.54-0.440.070.350.35-0.120.07-0.110.070.07
Click cells to compare fundamentals

About Hepion Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Hepion Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Hepion Pharmaceuticals investors use historical funamental indicators, such as Hepion Pharmaceuticals's Total Assets, to determine how well the company is positioned to perform in the future. Although Hepion Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Hepion Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hepion Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hepion Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hepion Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets18.1 M27.5 M
Intangibles To Total Assets 0.06  0.06 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:
Check out the analysis of Hepion Pharmaceuticals Correlation against competitors.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Hepion Stock analysis

When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.32)
Return On Assets
(0.72)
Return On Equity
(1.71)
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.